AbBaltis announces fully operational blood component processing department
The new department offers advanced plasma processing services including antibody enrichment and immunoglobulin depletion to support assay development.
See the latest news and media coverage for AbBaltis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biological sample supplier and research services provider
abbaltis.comLast updated
In short: AbBaltis entered the US market, expanded blood component processing, and grew its team in 2025-26.
The new department offers advanced plasma processing services including antibody enrichment and immunoglobulin depletion to support assay development.
The new department offers defibrinated, delipidated, buffer-exchanged, antibody-enriched, and depleted plasma, plus purified proteins, each batch with a Certificate of Analysis.
It processes plasma and serum to IVD developers' specifications, including delipidation and defibrination.
The company has supplied disease-state plasma for 16 years and now enters the US market, showcasing at Booth #916.
Founded in 2010 by Giedre Brandao, AbBaltis is a biotechnology SME focused on advancing blood diagnostics and supporting the global scientific community. Beyond innovative diagnostics...
A Kent biotechnology company that supplies blood plasma for lab testing is set to hit sales of £1m for the first time in 2020 after...
A small biological materials supplier is preparing its next wave of employees by launching a work experience programme. AbBaltis employs less than 10 people but...
Track AbBaltis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.